1. Home
  2. ELVN vs TPB Comparison

ELVN vs TPB Comparison

Compare ELVN & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • TPB
  • Stock Information
  • Founded
  • ELVN 2016
  • TPB 1988
  • Country
  • ELVN United States
  • TPB United States
  • Employees
  • ELVN N/A
  • TPB N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • TPB Tobacco
  • Sector
  • ELVN Health Care
  • TPB Consumer Discretionary
  • Exchange
  • ELVN Nasdaq
  • TPB Nasdaq
  • Market Cap
  • ELVN 1.2B
  • TPB 1.3B
  • IPO Year
  • ELVN 2020
  • TPB 2016
  • Fundamental
  • Price
  • ELVN $22.63
  • TPB $72.33
  • Analyst Decision
  • ELVN Strong Buy
  • TPB Strong Buy
  • Analyst Count
  • ELVN 5
  • TPB 4
  • Target Price
  • ELVN $41.20
  • TPB $73.75
  • AVG Volume (30 Days)
  • ELVN 721.5K
  • TPB 270.7K
  • Earning Date
  • ELVN 08-12-2025
  • TPB 07-31-2025
  • Dividend Yield
  • ELVN N/A
  • TPB 0.41%
  • EPS Growth
  • ELVN N/A
  • TPB N/A
  • EPS
  • ELVN N/A
  • TPB N/A
  • Revenue
  • ELVN N/A
  • TPB $384,032,000.00
  • Revenue This Year
  • ELVN N/A
  • TPB $21.66
  • Revenue Next Year
  • ELVN N/A
  • TPB $9.08
  • P/E Ratio
  • ELVN N/A
  • TPB N/A
  • Revenue Growth
  • ELVN N/A
  • TPB 24.54
  • 52 Week Low
  • ELVN $13.30
  • TPB $34.78
  • 52 Week High
  • ELVN $30.03
  • TPB $81.25
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 60.45
  • TPB 46.81
  • Support Level
  • ELVN $19.38
  • TPB $70.06
  • Resistance Level
  • ELVN $21.34
  • TPB $73.22
  • Average True Range (ATR)
  • ELVN 1.27
  • TPB 2.46
  • MACD
  • ELVN 0.11
  • TPB -0.46
  • Stochastic Oscillator
  • ELVN 88.47
  • TPB 33.91

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

Share on Social Networks: